Livewire Ergogenics Financial Statements (LVVV)
|
|
|
|
Report date
|
|
|
31.12.2021 |
31.12.2022 |
31.12.2023 |
31.12.2024 |
31.12.2025 |
|
31.12.2025 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
|
Revenue, bln rub |
? |
|
0.851 |
1.94 |
1.63 |
0.304 |
0.008 |
|
0.008 |
|
Operating Income, bln rub |
|
|
-2.49 |
0.645 |
0.830 |
0.119 |
-0.182 |
|
-0.182 |
|
EBITDA, bln rub |
? |
|
-2.68 |
1.07 |
1.22 |
0.322 |
-0.157 |
|
0.118 |
|
Net profit, bln rub |
? |
|
-3.43 |
0.684 |
0.922 |
0.079 |
-4.78 |
|
-4.78 |
|
|
OCF, bln rub |
? |
|
-0.400 |
0.396 |
0.682 |
0.125 |
-0.007 |
|
0.011 |
|
CAPEX, bln rub |
? |
|
0.067 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
FCF, bln rub |
? |
|
-0.467 |
0.396 |
0.682 |
0.125 |
-0.007 |
|
0.011 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
3.19 |
1.16 |
0.764 |
0.166 |
0.165 |
|
0.165 |
|
Cost of production, bln rub |
|
|
0.150 |
0.133 |
0.039 |
0.019 |
0.025 |
|
0.025 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
0.605 |
0.249 |
0.245 |
0.224 |
0.356 |
|
0.356 |
|
|
Assets, bln rub |
|
|
4.52 |
6.27 |
7.74 |
7.96 |
2.26 |
|
2.26 |
|
Net Assets, bln rub |
? |
|
0.912 |
2.03 |
3.11 |
3.24 |
-1.51 |
|
-1.51 |
|
Debt, bln rub |
|
|
2.85 |
3.20 |
3.34 |
3.35 |
3.05 |
|
3.05 |
|
Cash, bln rub |
|
|
0.200 |
0.076 |
0.028 |
0.011 |
0.001 |
|
0.001 |
|
Net debt, bln rub |
|
|
2.65 |
3.12 |
3.32 |
3.34 |
3.05 |
|
3.05 |
|
|
Ordinary share price, rub |
|
|
0.008 |
0.004 |
0.002 |
0.001 |
0.001 |
|
0.000 |
|
Number of ordinary shares, mln |
|
|
1 577 |
1 792 |
1 848 |
1 882 |
1 882 |
|
1 904 |
|
|
Market cap, bln rub |
|
|
13 |
6 |
4 |
1 |
1 |
|
1 |
|
EV, bln rub |
? |
|
15 |
9 |
7 |
4 |
4 |
|
4 |
|
Book value, bln rub |
|
|
1 |
2 |
3 |
3 |
-2 |
|
-2 |
|
|
EPS, rub |
? |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
0.00 |
|
FCF/share, rub |
|
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
0.00 |
|
BV/share, rub |
|
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
0.00 |
|
|
EBITDA margin, % |
? |
|
-314.6% |
55.1% |
74.4% |
105.9% |
-2 006% |
|
1 509% |
|
Net margin, % |
? |
|
-403.2% |
35.3% |
56.4% |
25.9% |
-61 057% |
|
-61 057% |
|
FCF yield, % |
? |
|
-3.66% |
6.32% |
19.4% |
11.0% |
-0.55% |
|
2.00% |
|
ROE, % |
? |
|
-376.3% |
33.7% |
29.6% |
2.43% |
316.2% |
|
316.2% |
|
ROA, % |
? |
|
-75.9% |
10.9% |
11.9% |
0.99% |
-211.5% |
|
-211.5% |
|
|
P/E |
? |
|
-3.72 |
9.17 |
3.81 |
14.3 |
-0.28 |
|
-0.12 |
|
P/FCF |
|
|
-27.3 |
15.8 |
5.15 |
9.05 |
-180.2 |
|
49.9 |
|
P/S |
? |
|
15.0 |
3.24 |
2.15 |
3.71 |
168.1 |
|
72.9 |
|
P/BV |
? |
|
14.1 |
3.09 |
1.13 |
0.35 |
-0.87 |
|
-0.38 |
|
EV/EBITDA |
? |
|
-5.76 |
8.80 |
5.61 |
13.9 |
-27.8 |
|
30.6 |
|
Debt/EBITDA |
|
|
-0.99 |
2.93 |
2.73 |
10.4 |
-19.4 |
|
25.8 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
|
|
|
|
|
0 |
|
|
CAPEX/Revenue, % |
|
|
7.91% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.05% |
|
| Livewire Ergogenics shareholders |
